Loading data
FLNANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Research and development expense | 26.59 m USD | 69.64 m USD | 89.42 m USD | 68.03 m USD | — |
| Operating profit | -95.39 m USD | -141.45 m USD | -105.96 m USD | -80.02 m USD | — |
| Income tax expense | 0 USD | 0 USD | — | — | 0 USD |
| Net income (reported basis) | -90.97 m USD | -24.34 m USD | -97.22 m USD | -76.25 m USD | — |
| Basic earnings per share | -1.88 USD/share | -0.53 USD/share | -2.32 USD/share | -1.9 USD/share | — |
| Diluted earnings per share | -1.88 USD/share | -1.46 USD/share | -2.32 USD/share | -1.9 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.